Zobrazeno 1 - 10
of 155
pro vyhledávání: '"Namiki, Yoshihisa"'
Publikováno v:
In Biomaterials February 2012 33(5):1682-1687
Publikováno v:
In Atherosclerosis 2005 179(1):97-102
Autor:
Namiki, Yoshihisa, Namiki, Tamami, Date, Masataka, Yanagihara, Kazuyoshi, Yashiro, Masakazu, Takahashi, Hiroshi
Publikováno v:
In Pharmacological Research 2004 50(1):65-76
Autor:
Sagawa Yukiko, Komita Hideo, Nagasaki Eijiro, Takahara Akitaka, Namiki Yoshihisa, Mitsunaga Makoto, Hara Eiichi, Homma Sadamu, Koido Shigeo, Ohkusa Toshifumi, Fujise Kiyotaka, Gong Jianlin, Tajiri Hisao
Publikováno v:
Journal of Translational Medicine, Vol 6, Iss 1, p 51 (2008)
Abstract Background Human hepatocellular carcinoma (HCC) cells express WT1 and/or carcinoembryonic antigen (CEA) as potential targets for the induction of antitumor immunity. In this study, generation of cytotoxic T lymphocytes (CTL) and regulatory T
Externí odkaz:
https://doaj.org/article/9516ae9f55bb455e89053c53516ada7f
Autor:
Namiki, Yoshihisa1 cancer_gene_therapy@ybb.ne.jp, Ueyama, Toshihiko2, Yoshida, Takayuki2, Watanabe, Ryoei3, Koido, Shigeo4, Namiki, Tamami5
Publikováno v:
Scientific Reports. 9/5/2014, p1-8. 8p.
Autor:
Namiki, Yoshihisa1 cancer_gene_therapy@ybb.ne.jp, Namiki, Tamami2, Yoshida, Hiroshi3, Ishii, Yukiko1,2, Tsubota, Akihito1, Koido, Shigeo4, Nariai, Kouichi5, Mitsunaga, Makoto4, Yanagisawa, Satoru6, Kashiwagi, Hideyuki6, Mabashi, Yasuo1, Yumoto, Yoko1, Hoshina, Sadayori1, Fujise, Kiyotaka1,4, Tada, Norio1,7
Publikováno v:
Nature Nanotechnology. Sep2009, Vol. 4 Issue 9, p598-606. 9p. 1 Diagram, 1 Chart, 5 Graphs.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Koido, Shigeo, Homma, Sadamu, Takahara, Akitaka, Namiki, Yoshihisa, Komita, Hideo, Nagasaki, Eijiro, Ito, Masaki, Nagatsuma, Keisuke, Uchiyama, Kan, Satoh, Kenichi, Ohkusa, Toshifumi, Gong, Jianlin, Tajiri, Hisao
Publikováno v:
Journal of Biomedicine and Biotechnology.
Although dendritic cell (DC)- based cancer vaccines induce effective antitumor activities in murine models, only limited therapeutic results have been obtained in clinical trials. As cancer vaccines induce antitumor activities by eliciting or modifyi
Autor:
Koido, Shigeo, Homma, Sadamu, Takahara, Akitaka, Namiki, Yoshihisa, Tsukinaga, Shintaro, Mitobe, Jimi, Odahara, Shunichi, Yukawa, Toyokazu, Matsudaira, Hiroshi, Nagatsuma, Keisuke, Uchiyama, Kan, Satoh, Kenichi, Ito, Masaki, Komita, Hideo, Arakawa, Hiroshi, Ohkusa, Toshifumi, Gong, Jianlin, Tajiri, Hisao
Publikováno v:
Clinical and Developmental Immunology.
Pancreatic cancer is a highly aggressive and notoriously difficult to treat. As the vast majority of patients are diagnosed at advanced stage of the disease, only a small population is curative by surgical resection. Although gemcitabine-based chemot
Autor:
Koido, Shigeo, Homma, Sadamu, Hara, Eiichi, Namiki, Yoshihisa, Ohkusa, Toshifumi, Gong, Jianlin, Tajiri, Hisao
Publikováno v:
Journal of Biomedicine and Biotechnology.
The aim of cancer vaccines is induction of tumor-specific cytotoxic T lymphocytes (CTLs) that can reduce the tumor mass. Dendritic cells (DCs) are potent antigen-presenting cells and play a central role in the initiation and regulation of primary imm